Consistent Efficacy of Apremilast in Patients with Psoriasis Regardless of Baseline Disease Severity or Special Area Involvement: Subgroup Analysis from PROMINENT
Abstract Introduction Psoriasis involvement in special areas (e.g., scalp or nails) is associated with a great disease burden yet it is often inadequately treated with topical treatments. The efficacy and tolerability of apremilast plus existing topical therapy in Japanese patients with mild to mode...
Saved in:
Main Authors: | Masatoshi Abe (Author), Yukari Okubo (Author), Hidetoshi Takahashi (Author), Koki Endo (Author), Siddharth Chaudhari (Author), Cynthia Deignan (Author), Hamid Amouzadeh (Author), Ryosuke Hino (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study
by: Yukari Okubo, et al.
Published: (2024) -
Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity
by: April W. Armstrong, et al.
Published: (2024) -
Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity
by: April W. Armstrong, et al.
Published: (2024) -
Dupilumab Reduces Urticaria Activity, Itch, and Hives in Patients with Chronic Spontaneous Urticaria Regardless of Baseline Serum Immunoglobulin E Levels
by: Marcus Maurer, et al.
Published: (2024) -
Apremilast
by: Nihal Kundakçı
Published: (2022)